Sunitinib
GeneID | Mean_1 | Mean_3 | StDev_1 | StDev_3 | T-Statistic | p-value | Symbol | Description | |
---|---|---|---|---|---|---|---|---|---|
1 | 19 | 3.0 | 2.4 | 0.6 | 0.1 | -1.605 | 0.2442 | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
2 | 9429 | 2.8 | 6.4 | 0.5 | 0.3 | 11.391 | 0.0013 | ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) |
3 | 213 | 3.2 | 2.8 | 0.4 | 0.5 | -1.148 | 0.3190 | ALB | albumin |
4 | 238 | 2.5 | 2.5 | 0.1 | 0.1 | 0.197 | 0.8553 | ALK | anaplastic lymphoma receptor tyrosine kinase |
5 | 9582 | 8.2 | 8.1 | 0.2 | 0.3 | -0.879 | 0.4371 | APOBEC3B | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B |
6 | 51761 | 2.8 | 4.2 | 0.2 | 0.2 | 8.068 | 0.0017 | ATP8A2 | ATPase, aminophospholipid transporter, class I, type 8A, member 2 |
7 | 9212 | 8.7 | 10.0 | 0.2 | 0.2 | 7.824 | 0.0014 | AURKB | aurora kinase B |
8 | 558 | 7.0 | 7.0 | 0.2 | 0.2 | -0.021 | 0.9840 | AXL | AXL receptor tyrosine kinase |
9 | 596 | 10.3 | 10.3 | 0.2 | 0.1 | 0.739 | 0.5268 | BCL2 | B-cell CLL/lymphoma 2 |
10 | 55589 | 5.2 | 6.6 | 0.1 | 0.1 | 12.885 | 0.0002 | BMP2K | BMP2 inducible kinase |
11 | 78996 | 9.9 | 11.0 | 0.2 | 0.1 | 9.881 | 0.0048 | C7orf49 | chromosome 7 open reading frame 49 |
12 | 836 | 8.2 | 8.0 | 0.3 | 0.2 | -1.211 | 0.3082 | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
13 | 947 | 2.6 | 2.4 | 0.1 | 0.1 | -2.834 | 0.0480 | CD34 | CD34 molecule |
14 | 920 | 12.3 | 12.1 | 0.1 | 0.3 | -1.157 | 0.3384 | CD4 | CD4 molecule |
15 | 81620 | 13.0 | 13.5 | 0.6 | 0.1 | 1.278 | 0.3241 | CDT1 | chromatin licensing and DNA replication factor 1 |
16 | 83548 | 10.1 | 10.1 | 0.0 | 0.2 | 0.698 | 0.5574 | COG3 | component of oligomeric golgi complex 3 |
17 | 1436 | 3.7 | 2.9 | 0.1 | 0.4 | -3.787 | 0.0406 | CSF1R | colony stimulating factor 1 receptor |
18 | 1437 | 2.3 | 2.3 | 0.0 | 0.0 | 0.420 | 0.7020 | CSF2 | colony stimulating factor 2 (granulocyte-macrophage) |
19 | 1455 | 10.9 | 11.0 | 0.1 | 0.1 | 1.296 | 0.2694 | CSNK1G2 | casein kinase 1, gamma 2 |
20 | 6387 | 7.9 | 8.5 | 0.3 | 0.3 | 2.040 | 0.1110 | CXCL12 | chemokine (C-X-C motif) ligand 12 |
21 | 114757 | 13.4 | 13.0 | 0.1 | 0.2 | -2.755 | 0.0760 | CYGB | cytoglobin |
22 | 1558 | 2.2 | 2.8 | 0.0 | 0.6 | 1.477 | 0.2775 | CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 |
23 | 4921 | 2.6 | 2.9 | 0.4 | 0.4 | 0.964 | 0.3899 | DDR2 | discoidin domain receptor tyrosine kinase 2 |
24 | 1950 | 2.3 | 2.4 | 0.0 | 0.1 | 1.016 | 0.4144 | EGF | epidermal growth factor |
25 | 1956 | 2.9 | 3.3 | 0.2 | 0.1 | 3.112 | 0.0782 | EGFR | epidermal growth factor receptor |
26 | 1999 | 10.5 | 10.5 | 0.1 | 0.7 | 0.018 | 0.9875 | ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
27 | 2048 | 5.7 | 5.8 | 0.3 | 0.2 | 0.700 | 0.5288 | EPHB2 | EPH receptor B2 |
28 | 2064 | 9.7 | 9.0 | 0.4 | 0.3 | -2.344 | 0.0865 | ERBB2 | erb-b2 receptor tyrosine kinase 2 |
29 | 2158 | 2.3 | 2.3 | 0.0 | 0.0 | 0.072 | 0.9471 | F9 | coagulation factor IX |
30 | 144717 | 7.2 | 7.6 | 0.2 | 0.2 | 2.499 | 0.0694 | FAM109A | family with sequence similarity 109, member A |
31 | 2258 | 4.8 | 6.2 | 0.4 | 0.4 | 4.282 | 0.0135 | FGF13 | fibroblast growth factor 13 |
32 | 2321 | 2.4 | 2.5 | 0.1 | 0.1 | 0.409 | 0.7102 | FLT1 | fms-related tyrosine kinase 1 |
33 | 2322 | 5.4 | 8.4 | 0.2 | 0.0 | 22.015 | 0.0014 | FLT3 | fms-related tyrosine kinase 3 |
34 | 2324 | 4.1 | 4.4 | 0.2 | 0.1 | 3.492 | 0.0353 | FLT4 | fms-related tyrosine kinase 4 |
35 | 2645 | 4.8 | 4.7 | 0.1 | 0.2 | -0.602 | 0.5904 | GCK | glucokinase (hexokinase 4) |
36 | 3043 | 2.4 | 2.4 | 0.0 | 0.0 | 0.209 | 0.8450 | HBB | hemoglobin, beta |
37 | 3091 | 9.2 | 9.4 | 0.1 | 0.0 | 3.235 | 0.0743 | HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
38 | 3265 | 10.7 | 10.7 | 0.2 | 0.4 | -0.278 | 0.8001 | HRAS | Harvey rat sarcoma viral oncogene homolog |
39 | 56912 | 9.6 | 9.7 | 0.2 | 0.2 | 0.834 | 0.4511 | IFT46 | intraflagellar transport 46 |
40 | 3558 | 2.5 | 2.4 | 0.1 | 0.1 | -0.771 | 0.4998 | IL2 | interleukin 2 |
41 | 3562 | 2.5 | 2.6 | 0.1 | 0.2 | 0.361 | 0.7433 | IL3 | interleukin 3 |
42 | 3569 | 2.3 | 2.3 | 0.0 | 0.0 | -0.440 | 0.6964 | IL6 | interleukin 6 |
43 | 3630 | 3.6 | 4.1 | 0.4 | 0.4 | 1.716 | 0.1617 | INS | insulin |
44 | 3791 | 2.4 | 2.3 | 0.0 | 0.1 | -0.496 | 0.6472 | KDR | kinase insert domain receptor |
45 | 3815 | 2.3 | 2.3 | 0.1 | 0.0 | -0.184 | 0.8629 | KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
46 | 3939 | 13.5 | 13.5 | 0.2 | 0.3 | 0.040 | 0.9697 | LDHA | lactate dehydrogenase A |
47 | 4217 | 7.7 | 7.7 | 0.1 | 0.1 | 0.239 | 0.8256 | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 |
48 | 5595 | 8.9 | 9.2 | 0.3 | 0.1 | 1.920 | 0.1525 | MAPK3 | mitogen-activated protein kinase 3 |
49 | 4233 | 9.9 | 11.6 | 0.1 | 0.1 | 28.016 | 0.0001 | MET | MET proto-oncogene, receptor tyrosine kinase |
50 | 4318 | 10.6 | 9.4 | 0.1 | 0.3 | -6.225 | 0.0138 | MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
51 | 2475 | 8.9 | 9.1 | 0.0 | 0.1 | 3.319 | 0.0559 | MTOR | mechanistic target of rapamycin (serine/threonine kinase) |
52 | 4846 | 7.8 | 7.0 | 0.1 | 0.3 | -4.351 | 0.0334 | NOS3 | nitric oxide synthase 3 (endothelial cell) |
53 | 10133 | 7.3 | 7.4 | 0.2 | 0.1 | 1.199 | 0.3034 | OPTN | optineurin |
54 | 54995 | 11.7 | 11.5 | 0.1 | 0.1 | -2.995 | 0.0418 | OXSM | 3-oxoacyl-ACP synthase, mitochondrial |
55 | 57144 | 2.9 | 2.4 | 1.0 | 0.0 | -0.943 | 0.4450 | PAK7 | p21 protein (Cdc42/Rac)-activated kinase 7 |
56 | 5156 | 2.3 | 2.3 | 0.0 | 0.0 | 0.365 | 0.7443 | PDGFRA | platelet-derived growth factor receptor, alpha polypeptide |
57 | 5159 | 2.3 | 2.3 | 0.0 | 0.0 | 0.990 | 0.3792 | PDGFRB | platelet-derived growth factor receptor, beta polypeptide |
58 | 5260 | 4.8 | 4.7 | 0.2 | 0.0 | -0.542 | 0.6382 | PHKG1 | phosphorylase kinase, gamma 1 (muscle) |
59 | 5261 | 8.4 | 8.7 | 0.3 | 0.1 | 1.458 | 0.2555 | PHKG2 | phosphorylase kinase, gamma 2 (testis) |
60 | 55558 | 11.7 | 11.8 | 0.2 | 0.2 | 0.458 | 0.6717 | PLXNA3 | plexin A3 |
61 | 5468 | 2.3 | 4.0 | 0.0 | 0.5 | 5.713 | 0.0291 | PPARG | peroxisome proliferator-activated receptor gamma |
62 | 7001 | 12.0 | 12.1 | 0.1 | 0.0 | 3.370 | 0.0339 | PRDX2 | peroxiredoxin 2 |
63 | 5728 | 10.1 | 9.8 | 0.0 | 0.1 | -3.208 | 0.0714 | PTEN | phosphatase and tensin homolog |
64 | 5923 | 3.0 | 2.3 | 1.2 | 0.1 | -0.992 | 0.4255 | RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 |
65 | 677775 | 7.5 | 7.5 | 0.1 | 0.1 | -0.090 | 0.9327 | SCARNA5 | small Cajal body-specific RNA 5 |
66 | 29072 | 8.7 | 8.7 | 0.0 | 0.0 | 0.189 | 0.8593 | SETD2 | SET domain containing 2 |
67 | 788 | 8.3 | 7.5 | 0.1 | 0.4 | -3.731 | 0.0611 | SLC25A20 | solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
68 | 9748 | 9.5 | 9.6 | 0.1 | 0.2 | 0.590 | 0.6044 | SLK | STE20-like kinase |
69 | 23583 | 9.9 | 9.9 | 0.1 | 0.0 | 0.634 | 0.5814 | SMUG1 | single-strand-selective monofunctional uracil-DNA glycosylase 1 |
70 | 6750 | 2.5 | 2.5 | 0.1 | 0.3 | 0.480 | 0.6656 | SST | somatostatin |
71 | 6774 | 7.9 | 7.4 | 0.2 | 0.1 | -4.219 | 0.0140 | STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
72 | 8576 | 9.9 | 9.6 | 0.3 | 0.3 | -1.108 | 0.3326 | STK16 | serine/threonine kinase 16 |
73 | 9263 | 2.5 | 2.4 | 0.2 | 0.0 | -0.981 | 0.4244 | STK17A | serine/threonine kinase 17a |
74 | 7010 | 2.3 | 2.3 | 0.0 | 0.0 | -0.436 | 0.6866 | TEK | TEK tyrosine kinase, endothelial |
75 | 7030 | 9.5 | 9.5 | 0.1 | 0.1 | 0.636 | 0.5634 | TFE3 | transcription factor binding to IGHM enhancer 3 |
76 | 7038 | 3.3 | 3.8 | 0.2 | 0.2 | 3.201 | 0.0345 | TG | thyroglobulin |
77 | 7108 | 10.5 | 9.8 | 0.2 | 0.2 | -5.011 | 0.0074 | TM7SF2 | transmembrane 7 superfamily member 2 |
78 | 7157 | 7.9 | 7.4 | 0.3 | 0.5 | -1.440 | 0.2378 | TP53 | tumor protein p53 |
79 | 7170 | 8.9 | 9.2 | 0.2 | 0.2 | 2.532 | 0.0661 | TPM3 | tropomyosin 3 |
80 | 7248 | 7.0 | 6.6 | 0.5 | 0.0 | -1.693 | 0.2299 | TSC1 | tuberous sclerosis 1 |
81 | 10103 | 10.3 | 8.7 | 0.2 | 0.7 | -3.976 | 0.0393 | TSPAN1 | tetraspanin 1 |
82 | 7422 | 8.5 | 8.5 | 0.5 | 0.2 | 0.009 | 0.9937 | VEGFA | vascular endothelial growth factor A |
83 | 7424 | 6.7 | 6.8 | 0.3 | 0.4 | 0.285 | 0.7901 | VEGFC | vascular endothelial growth factor C |
84 | 7450 | 5.0 | 3.7 | 0.2 | 0.1 | -11.198 | 0.0004 | VWF | von Willebrand factor |
85 | 7515 | 12.9 | 12.8 | 0.4 | 0.2 | -0.351 | 0.7513 | XRCC1 | X-ray repair complementing defective repair in Chinese hamster cells 1 |
86 | 7525 | 9.9 | 9.8 | 0.1 | 0.1 | -0.554 | 0.6091 | YES1 | YES proto-oncogene 1, Src family tyrosine kinase |
87 | 22882 | 9.6 | 10.2 | 0.1 | 0.3 | 3.424 | 0.0581 | ZHX2 | zinc fingers and homeoboxes 2 |